Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (891-900 of 1,298) with videos related to

Pageof 130
Sort By:
Cancer Research|December 11, 2013
A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibitionHailing Cheng, Pixu Liu, Fan Zhang, et al.
Molecular Cancer Therapeutics|May 7, 2009
Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumorChangye Y Zou, Kerrington D Smith, Quan-Sheng Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2013
Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancerJennifer B Dennison, Jennifer R Molina, Shreya Mitra, et al.
Orphanet Journal of Rare Diseases|July 3, 2016
TRNT1 deficiency: clinical, biochemical and molecular genetic featuresYehani Wedatilake, Rojeen Niazi, Elisa Fassone, et al.
Plos One|October 7, 2020
Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNANoriyuki Sasaki, Takeshi Iwaya, Takehiro Chiba, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 3, 2010
Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrenceMeera Nanjundan, Lauren Averett Byers, Mark S Carey, et al.
Oncogene|September 22, 2010
Vimentin is a novel AKT1 target mediating motility and invasionQ-S Zhu, K Rosenblatt, K-L Huang, et al.
Journal of the National Cancer Institute|March 11, 2021
Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor TherapyYing Jing, Yongchang Zhang, Jing Wang, et al.
Molecular Cell|May 21, 2011
Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signalsYaara Zwang, Aldema Sas-Chen, Yotam Drier, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Mechanistic basis of staphylococcal interspecies competition for skin colonizationJoseph J Maciag, Constance Chantraine, Krista B Mills, et al.
Pageof 130

Showing results (891-900 of 1,298) with videos related to

Sort By:
Pageof 130
Cancer Research|December 11, 2013
A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibitionHailing Cheng, Pixu Liu, Fan Zhang, et al.
Molecular Cancer Therapeutics|May 7, 2009
Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumorChangye Y Zou, Kerrington D Smith, Quan-Sheng Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2013
Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancerJennifer B Dennison, Jennifer R Molina, Shreya Mitra, et al.
Orphanet Journal of Rare Diseases|July 3, 2016
TRNT1 deficiency: clinical, biochemical and molecular genetic featuresYehani Wedatilake, Rojeen Niazi, Elisa Fassone, et al.
Plos One|October 7, 2020
Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNANoriyuki Sasaki, Takeshi Iwaya, Takehiro Chiba, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 3, 2010
Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrenceMeera Nanjundan, Lauren Averett Byers, Mark S Carey, et al.
Oncogene|September 22, 2010
Vimentin is a novel AKT1 target mediating motility and invasionQ-S Zhu, K Rosenblatt, K-L Huang, et al.
Journal of the National Cancer Institute|March 11, 2021
Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor TherapyYing Jing, Yongchang Zhang, Jing Wang, et al.
Molecular Cell|May 21, 2011
Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signalsYaara Zwang, Aldema Sas-Chen, Yotam Drier, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Mechanistic basis of staphylococcal interspecies competition for skin colonizationJoseph J Maciag, Constance Chantraine, Krista B Mills, et al.
Pageof 130